Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.13M Buy
28,247
+3,070
+12% +$499K 1.77% 26
2025
Q4
$4.91M Buy
25,177
+5,729
+29% +$1.36M 1.92% 26
2025
Q3
$5.47M Sell
19,448
-8,875
-31% -$2.26M 0.99% 29
2025
Q2
$6.19M Buy
28,323
+1,192
+4% +$192K 3.29% 7
2025
Q1
$3.79M Buy
27,131
+5,271
+24% +$858K 2.16% 23
2024
Q4
$3.64M Buy
+21,860
New +$3.88M 2.01% 27
2024
Q3
Sell
-28,859
Closed -$4.07M 53
2024
Q2
$4.07M Sell
28,859
-1,509
-5% -$187K 2.42% 22
2024
Q1
$3.81M Sell
30,368
-562
-2% -$64.3K 2.33% 25
2023
Q4
$3.26M Buy
30,930
+27,530
+810% +$3M 2.15% 24
2023
Q3
$360K Hold
3,400
0.2% 52
2023
Q2
$405K Hold
3,400
0.21% 51
2023
Q1
$316K Hold
3,400
0.19% 60
2022
Q4
$278K Buy
+3,400
New +$258K 0.5% 35

Other funds holding ORCL

Saranac Partners's ORCL Position: Q1 2026 in Review

Saranac Partners increased its Oracle (ORCL) stake by 12% in Q1 2026, buying an estimated $499K and bringing the position to 28,247 shares worth $4.13M. The position accounts for 1.77% of the portfolio, ranked #26.

Saranac Partners first reported a position in ORCL in Q4 2022 and has held it in 13 quarters since. The position peaked at $6.19M in Q2 2025. 3,488 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Saranac Partners held 28,247 shares of Oracle worth $4.13M as of Q1 2026.
  • Saranac Partners bought 3,070 Oracle shares in Q1 2026, an estimated $499K.
  • Oracle made up 1.77% of Saranac Partners's portfolio in Q1 2026, its #26 holding.
  • Saranac Partners first reported a position in Oracle in Q4 2022 and has held it in 13 quarters since.
  • Saranac Partners's Oracle position peaked at $6.19M in Q2 2025.
  • 3,488 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Saranac Partners's 13F filing for Q1 2026, filed 15 May 2026.